cd34-tk75 transduced donor lymphocytes

Cell therapyexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2010 (NCT00871702)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetImmunity, passive

    Immunity, passive

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • cd34-tk75 transduced donor lymphocytes

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00871702Phase 1Oct 1, 2010Washington University in St. Louis
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Washington University in St. LouisAcademic/Hospital1112010
1 organizations
Page 1 / 1